RxDoctor Payments Data

Rocio Cardona, MD

Dermatology · Carolina, PRNPI 1003261280

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.8% of the total across 206 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by AbbVie at 49.3% of the total.

$6,989in general payments, 2019–2025

Across 206 payments — averaging $33.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Johnson & Johnson$1K
  • Sanofi$561
  • E.r. Squibb & Sons, L.L.C.$492
  • Eli Lilly Export S.A. Puerto Rico Branch$340
  • PBG Puerto Rico LLC$196
  • plus $878 from 9 others

What the payments were for

  • Food & beverage$6,55994%
  • Education$4306%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)107$3,443
Johnson & Johnson(2 entities)29$1,078
Sanofi12$561
E.r. Squibb & Sons, L.L.C.17$492
Eli Lilly Export S.A. Puerto Rico Branch13$340
PBG Puerto Rico LLC10$196
Genentech USA, Inc.3$156
Pfizer2$134
Janssen Scientific Affairs, LLC1$125
Galderma Laboratories, L.p.1$124
Lilly USA, LLC2$100
Revance Therapeutics, Inc.1$92
Novartis4$64
Sanofi-aventis U.S. LLC2$45
Pfizer Pharmaceuticals LLC2$36

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,989 in reported general payments places this provider in the 85th percentile of 108 dermatology providers in Puerto Rico.

See all dermatology providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$8,035
Medicare patients
34
Services billed
91

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab28$106,615
Betamethasone Valerate471$20,703
Ketoconazole756$20,267
Ciclopirox251$8,857
Ammonium Lactate232$6,919
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc97$6,047
Clobetasol Propionate51$4,178
Desonide67$2,961
Metronidazole46$2,816
Triamcinolone Acetonide294$2,737
Tacrolimus23$1,826
Mometasone Furoate62$1,493
Mupirocin111$1,147
Gentamicin Sulfate20$1,110
Clindamycin Phosphate36$1,060

Paid to pharmacies, not to this prescriber.

Other dermatology in Carolina

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →